Since we won't get data until late summer or early fall of 2022, 2023 seems like the logical approval date. Unless, something extraordinary happens. For ALZ BTW.
If you invested here 'cuz of Patrick Cox's recommendation in 2009, then 3 "Cheers" for you ... we've been here for 11+ years, too. Hopefully, for you and many others, Blarcamesine is given some form of fda "green light" or access for those in need.